Supernus Pharmaceuticals Inc (NASDAQ:SUPN)

48.50
Delayed Data
As of Apr 20
 -0.35 / -0.72%
Today’s Change
29.95
Today|||52-Week Range
50.05
+21.71%
Year-to-Date
No recent news for Supernus Pharmaceuticals Inc.

Today’s Trading

Previous close48.85
Today’s open48.70
Day’s range47.51 - 49.45
Volume603,250
Average volume (3 months)641,797
Market cap$2.3B
Data as of 4:00pm ET, 04/20/2018

Growth & Valuation

Earnings growth (last year)-38.64%
Earnings growth (this year)+74.54%
Earnings growth (next 5 years)+40.10%
Revenue growth (last year)+40.57%
P/E ratio44.9
Price/Sales7.03
Price/Book8.60

Competitors

 Today’s
change
Today’s
% change
FOLDAmicus Therapeutics ...-0.43-2.94%
PRTAProthena Corporation...+1.87+5.35%
IRWDIronwood Pharmaceuti...-0.29-1.65%
HZNPHorizon Pharma PLC-0.12-0.87%
Data as of 4:00pm ET, 04/20/2018

Financials

Next reporting dateMay 14, 2018
EPS forecast (this quarter)$0.24
Annual revenue (last year)$302.2M
Annual profit (last year)$57.3M
Net profit margin18.95%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, CEO, Secretary &
Director
Jack A. Khattar
Chief Financial Officer &
Vice President
Gregory S. Patrick
Corporate headquarters
Rockville, Maryland

Forecasts